Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Qinghua Formula is a Traditional Chinese Medicine (TCM) herbal compound developed for the treatment of various chronic metabolic and gastrointestinal conditions, including type 2 diabetes mellitus, non-erosive reflux disease (NERD), and chronic kidney disease. The formula is based on the TCM principles of strengthening the spleen (Jianpi) and clearing heat/dampness (Qinghua). Clinical research, primarily conducted by Shuguang Hospital (affiliated with Shanghai University of TCM) and Xiyuan Hospital, has investigated its ability to modulate glucagon-like peptide-1 (GLP-1) concentrations in diabetic patients and its efficacy in reducing symptoms of NERD, potentially allowing for the tapering of proton pump inhibitor (PPI) therapy. It is typically administered orally as a decoction or in granule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jianpi qinghua formula.